I am looking for some updates on expectations for the relationship between an OEM and an OBL. I am aware that MHRA Bulletin 19 was pulled based on 2013/473/EU and at least two draft guidance docs have been proposed in replacement. But I have no further news. Please advise if you have further details.
Thanks
Mitch
----------------------------------------------------
Mitch Johnson
Director, Regulatory Affairs
IntriCon Corp
---------------------------------------------------